Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03201120 · ClinicalTrials.gov registry record · NA
Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 3,595
- Enrollment target
NCT03201120: Completed NA study, sponsored by University of Pennsylvania.
NCT03201120 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 3,595 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (156% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03201120, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,595 participants
- Enrollment target
Study Summary
Phase 3b of the research will be a laboratory experiment that uses an experimental and analytic design that is parallel to that used in Phase 3a, the online experiment. The primary objective of Phase 3b is to assess physiological response (i.e., eye tracking) to different message appeals of the audio-visual messages used in Phase 3a on respondents' behavioral intentions and UV-related behavioral choices post-exposure. Including time for preparation, viewing, and removal of the monitoring equipment, the message viewing session will take about 45 minutes per session.
Primary Outcome
Questionnaire measures will be completed using an iPad with Qualtrics software. Participants will be asked to evaluate each message for its argument strength, emotional appeal, and themes; participants will also be asked about their intentions and beliefs related to each behavior. The research technician will not initiate a conversation with the participant during the experimental session except to give instructions.
Interventions
- BEHAVIORAL Outdoor Sun Behavior
- BEHAVIORAL Indoor Tanning Behavior
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,595 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2017-09-28 |
| Phase | NA |
What the finished NCT03201120 record still lists
NCT03201120 is an interventional study that assigns participants to a tested intervention. Its 3,595 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (156% higher).
The record links to 0 conditions, and to 2 interventions - of which Outdoor Sun Behavior is the first listed.
NCT03201120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03201120 about?
NCT03201120 is a clinical study titled "Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing". Phase 3b of the research will be a laboratory experiment that uses an experimental and analytic design that is parallel to that used in Phase 3a, the online experiment. The primary objective of Phase 3b is to assess physiological response (i.e., eye tracking) to different message appeals of the audi...
What is the current status of trial NCT03201120?
This trial is currently completed. It is a NA study. The enrollment target is 3,595 participants. The study started on 2017-03-29. Estimated completion is 2017-09-28.
What interventions are being tested in trial NCT03201120?
The interventions under investigation include: Outdoor Sun Behavior (BEHAVIORAL), Indoor Tanning Behavior (BEHAVIORAL).
Who is sponsoring clinical trial NCT03201120?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03201120's enrollment target sits among peer trials
3,595 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
- NCT06919419 · 3,600 participants · NA
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
- NCT07091032 · 3,600 participants · NA
Building Connections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI